Form 4 for ABBV AbbVie
Accepted 2021-12-17 00:00:00 ET · period of report 2021-12-15 · accession 0001179110-21-011109 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-17 | 2021-12-15 | ABBV | Stewart Jeffrey Ryan | EVP, Chief Commercial Off | S - Sale | $128.00 | -2,152 | 47.1K | -4% | -$275.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2021-12-15 | S | D | 2,152 | $128.00 | 47,104 | D | — | — |